Should a 62YearOld Claim Social Security Now and Switch to Survivors Benefit at 67 A BreakEven Analysis The AI Economy Reshapes the American Dream BlueCollar Workers Gain Ground Amazon Reports BestEver Thanksgiving Holiday Week with Record Sales and Items Sold Shell SHEL Upgraded to Buy Following ARC Resources Deal Chinese Drone Shipments Face Sharp Decline Amid Domestic Restrictions and US Ban SpaceX Poised for Swift Index Inclusion Under Revised FTSE Rules 374Water Inc SCWO Q1 2026 Earnings Net Loss Widens as Development Continues Without Revenue PLBY Q1 2026 Earnings Significant EPS Miss Amidst Strategic Transformation Disc Medicine Q1 2026 Earnings NarrowerThanExpected Loss Offsets Lack of Revenue Stock Edges Down MED Q1 2026 Earnings EPS Surprises to the Upside but Stock Declines TATT Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Drops Over 5 ANIP Q1 2026 Earnings Stellar EPS Surge of 54 Above Estimates Nuveen California Municipal Income Fund NKX Records Modest Gain as Yield Environment Stabilizes Lithium Americas Corp LAC Rises 246 as It Approaches Key Resistance Near 524 MAIA Biotechnology Inc MAIA Gains 391 as Biotech Momentum Lifts Shares from Support Levels 60 Degrees Pharmaceuticals SXTP Holds Near Support After Minor Decline Fifth Era Acquisition Corp I FERA Holds Steady at 1038 as SPAC Market Awaits Catalyst Enhanced Games Backed by Donald Trump Jr and Peter Thiel Set for Las Vegas Debut STRK Q1 2026 Earnings Significant Earnings Miss Despite Modest Stock Gain Piper Sandler PIPR Faces Headwinds Stock Slips 22 Amid Market Pressure Google Advances Wearable AI with Upcoming Smart Glasses Release Apples Record High Rally Faces Key Test at June WWDC as AI Strategy Takes Center Stage China Emerges as Key Competitor in Humanoid Robotics Race Says Elon Musk Chinas Commerce Minister Skips APEC Opening Amid Urgent Official Business Trade Representative Chairs Meeting Automation Threatens 69 of Jobs in India World Bank Data Suggests Home Equity Borrowing Costs Remain Low but Fed Rate Path Could Shift Borrowing Calculus Citius Pharmaceuticals Draws Analyst Coverage as LYMPHIR Commercial Launch Gains Momentum